Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9417 - 9424 of 12008 results
Why Directors and Officers Should Demand a Separate Indemnification Agreement
May 26, 2015| Blog| Viewpoint
FDA Makes More Electronic Submissions Mandatory
May 22, 2015| Blog| Viewpoint
The NAI Issues Privacy Guidelines For Interest-Based Advertising, Ad Delivery and Reporting
May 22, 2015| Blog| Viewpoint
USCIS Releases Guidance and Frequently Asked Questions for H-4 Employment Authorization Applications
May 22, 2015| Advisory| Viewpoint
Nation’s Wind Power Potential Assessed in DOE Report
May 21, 2015| Blog| Viewpoint
Duty to Monitor Investments Extends Statute of Limitations for Fiduciary Breach Claim Says Supreme Court
May 20, 2015| Blog| Viewpoint
Premium Processing of H-1B Extensions Suspended as of May 26
May 20, 2015| Alert| Viewpoint
ML Strategies: 21st Century Cures and Other Health Legislation Markup
May 20, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|